Jalalon, Wilma A.
HRN: 27-82-57 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
RIFAXIMIN 200MG (TAB)
09/24/2025
10/01/2025
PO
200mg
Q12
AGE
Checking Initial Appropriateness
09/24/2025
RIFAXIMIN 200MG (TAB)
09/24/2025
10/01/2025
PO
200mg
Q8
AGE
Checking Initial Appropriateness
09/24/2025
RIFAXIMIN 200MG (TAB)
09/24/2025
10/01/2025
PO
400mg
TID
AGE
Checking Initial Appropriateness